reuters.com
TL;DR
LSD therapy-related biotech Definium is involved in a lawsuit alleging trade secret theft. The case is framed as a legal dispute in which Definium sues over alleged misappropriation tied to LSD therapy development. The dispute matters for the psychedelics industry because it highlights how IP protection and trade secret enforcement may shape funding, partnerships, and timelines for LSD-therapy programs.
These entries start auto-generated and improve with human input. Your contributions help!
Published Feb 2, 2026 · Added Mar 6, 2026